Materials and methods for protecting against neuromas

Patent metadata

Field	Value
Publication number	US-10952806-B2
Application number	US-201715496578-A
Country	US
Kind code	B2
Filing date	Apr 25, 2017
Priority date	Sep 25, 2012
Publication date	Mar 23, 2021
Grant date	Mar 23, 2021

Abstract

The subject invention provides devices and methods for alleviating discomfort associated with neuroma formation. The devices and methods of the invention effectively use the body's natural response of reconstructing implanted biomaterials to minimize the size of, isolate, and protect a neuroma. In preferred embodiments, the subject device is a cylindrical cap, wherein the internal chamber of the cylindrical cap physically partitions the nerve to enable an arrangement of nerve fibers (as opposed to haphazardly arranged nerve fibers often produced in neuromas). Tabs arranged on the outside of the cap can be used to manipulate the cap into place on a nerve. The open end can also be configured with flaps that can be used to widen the open end for easier insertion of the nerve into the cap. In addition, the cap's material remodels into a tissue cushion after implantation, which protects the neuroma from being stimulated and inducing pain.

First claim

We claim:

1. A sterile cap comprising:
an external body having a distal end, a proximal end with a single opening, and an internal chamber between the distal end and the proximal end, where the external body comprises a biomaterial that remodels around a terminal nerve end to form a tissue cushion;
at least one divider within the internal chamber that subdivides at least a portion of the internal chamber, at the distal end, where the at least one divider comprises a biomaterial that remodels around the separate channels to form a tissue cushion between the subdivided portions of the internal chamber; and
a retaining cavity between the single opening at the proximal end and the at least one divider.

2. The cap according to claim 1 , wherein the biomaterial is selected from the group consisting of: high density polyethylene (HDPE), polyethylene glycol (PEG) hydrogel, and purified proteins from human or animal sources.

3. The cap according to claim 1 , wherein the biomaterial is selected from the group consisting of: small intestine submucosa (SIS), amnion, dermis, collagen and decellularized fascia.

4. The cap according to claim 1 , wherein the at least one divider comprises at least one of: a panel, a spiral shaped wall, and concentric tubes.

5. The cap according to claim 1 , further comprising at least one tab extending from the external body.

6. The cap according to claim 5 , wherein the at least one tab extends from one or more of: a side of the external body, the distal end of the external body, and an edge of the single opening in the external body.

7. The cap according to claim 1 , further comprising at least one flap configured around the single opening of the external body, where the at least one flap forms a slot to increase the size of the single opening and wherein the at least one flap is adapted to be wrapped around the terminal nerve end to close the slot and reduce the size of the single opening around the terminal nerve end.

8. The cap according to claim 7 , wherein the at least one divider comprises at least one of: a panel, a spiral shaped wall, and concentric tubes.

9. The cap according to claim 7 , further comprising at least one tab extending from the external body.

10. The cap according to claim 9 , wherein the at least one tab extends from one or more of: a side of the external body, the distal end of the external body, and an edge of the single opening in the external body.

11. A method for covering and containing a neuroma mass at a terminal nerve end, comprising:
positioning a cap, according to claim 1 , at or near to a terminal nerve end prior to neuroma development,
inserting the terminal nerve end through the single opening into the retaining cavity internal chamber, and
securing the cap to the terminal nerve end to contain the neuroma mass as it develops.

12. A method for covering and containing a neuroma mass at a terminal nerve end comprising:
positioning a cap, according to claim 5 , at or near to a terminal nerve end prior to neuroma development;
inserting the terminal nerve end through the single opening into the retaining cavity; and
securing the cap to the terminal nerve end to contain the neuroma mass as it develops.

13. The method of claim 12 , further comprising using the at least one tab to manipulate the cap onto the terminal nerve end.

14. The method of claim 12 , further comprising attaching the at least one tab to other structures to secure the position of the cap and terminal nerve end therein.

15. A method for covering and containing a neuroma mass at a terminal nerve end comprising:
positioning a cap, according to claim 7 , at or near to a terminal nerve end prior to neuroma development;
inserting the terminal nerve end through the single opening into the retaining cavity; and
securing the cap to the terminal nerve end to contain the neuroma mass as it develops.

16. The method of claim 15 , further comprising spreading the flap before inserting the terminal nerve end into the retaining cavity.

17. A method for covering and containing a neuroma mass at a terminal nerve end comprising:
positioning a cap, according to claim 9 , at or near to a terminal nerve end prior to neuroma development;
spreading the flap;
after spreading the flap, inserting the terminal nerve end into the retaining cavity; and
securing the cap to the terminal nerve end to contain the neuroma mass as it develops.

18. The method of claim 17 , further comprising using the at least one tab to manipulate the cap onto the terminal nerve end.

19. The method of claim 17 , further comprising attaching the at least one tab to other structures to secure the position of the cap and terminal nerve end therein.

20. A method for preventing neuroma formation at a terminal nerve end comprising:
positioning a cap, according to claim 1 , at or near to a terminal nerve end;
inserting the terminal nerve end through the single opening into the retaining cavity; and
securing the cap to the terminal nerve end to contain the neuroma mass as it develops.

21. A method for preventing neuroma formation at a terminal nerve end comprising:
positioning a cap, according to claim 5 , at or near to a terminal nerve end;
inserting the terminal nerve end through the single opening into the retaining cavity; and
securing the cap to the terminal nerve end.

22. The method of claim 21 , further comprising using the at least one tab to manipulate the cap onto the terminal nerve end.

23. The method of claim 21 , further comprising attaching the at least one tab to other structures to secure the position of the cap and terminal nerve end therein.

24. A method for preventing neuroma formation at a terminal nerve end comprising:
positioning a cap, according to claim 7 , at or near to a terminal nerve end;
inserting the terminal nerve end through the single opening into the retaining cavity; and
securing the cap to the terminal nerve end.

25. The method of claim 24 , further comprising spreading the flap before inserting the terminal nerve end into the retaining cavity.

26. A method for preventing neuroma formation at a terminal nerve end comprising:
positioning a cap, according to claim 9 , at or near to a terminal nerve end;
spreading the flap;
after spreading the flap, inserting the terminal nerve end into the retaining cavity and
securing the cap to the terminal nerve end.

27. The method of claim 26 , further comprising using the at least one tab to manipulate the cap onto the terminal nerve end.

28. The method of claim 26 , further comprising attaching the at least one tab to other structures to secure the position of the cap and terminal nerve end therein.

29. A method for protecting from external stimuli a neuroma mass at a terminal nerve end comprising:
positioning a cap, according to claim 1 , at or near to a terminal nerve end;
inserting the terminal nerve end through the single opening into the retaining cavity; and
securing the cap to the terminal nerve end to protect the neuroma mass as it develops.

30. A method for protecting from external stimuli a neuroma mass at a terminal nerve end comprising:
positioning a cap, according to claim 5 , at or near to a terminal nerve end prior to neuroma development;
inserting the terminal nerve end through the single opening into the retainin

Assignees

• Axogen Corp

Inventors

• Deister Curt
• Simon Crystal
• Faleris Jennifer

Classifications

• A61L31/04 Primary

  Macromolecular materials · CPC title

• A61L27/3675

  Nerve tissue, e.g. brain, spinal cord, nerves, dura mater · CPC title

• A61L31/06

  obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds {(A61L31/041 takes precedence)} · CPC title

• A61L31/048

  obtained by reactions only involving carbon-to-carbon unsaturated bonds (A61L31/041 takes precedence) · CPC title

• A61L31/005

  Ingredients of undetermined constitution or reaction products thereof · CPC title